Dasatinib is a kinase inhibitor used to treat certain types of leukemia in both adults and children 1 year of age and older, including cases where previous treatment were not effective or tolerated.
The Nourishing Change Conference will convene leaders across healthcare sectors for innovative dialogue and engagement on nutrition security, care delivery, community and mental well-being.